Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center

Michele Carron, Fabio Baratto, Francesco Zarantonello, Carlo Ori

ClinicoEconomics and Outcomes Research · 2016 · 56 citations · 41 references

DOIFull text

Open access

Abstract

Sugammadex eliminated PORC and associated morbidities. In our center, sugammadex reduced the costs of NMB management and promoted rapid turnover of patients in operating rooms, with total cost-effectiveness that counteracts the disadvantages of its high cost.

References

41